NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,785,407 | +166.9% | 19,680 | +123.7% | 0.26% | +18.6% |
Q3 2022 | $669,000 | -99.9% | 8,798 | -6.8% | 0.22% | -19.2% |
Q2 2022 | $798,065,000 | +109074.4% | 9,441 | +13.3% | 0.27% | +34.3% |
Q1 2022 | $731,000 | +103.6% | 8,335 | +90.0% | 0.20% | +54.7% |
Q3 2021 | $359,000 | +20.1% | 4,387 | +33.8% | 0.13% | +13.3% |
Q2 2021 | $299,000 | +67.0% | 3,280 | +56.9% | 0.11% | +11.9% |
Q1 2021 | $179,000 | – | 2,091 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |